Akamai Technologies AKAM · NASDAQ
$87.81 -4.89% (-$4.51)
Summary
48 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for $800.0M in the last fiscal year, 6.0% of its market value.
- It has been profitable 6 years in a row.
What to watch
- Repaying its net debt would take 6.1 years of operating profit.
- The share price is above the Bulios Fair Price.
- Revenue grew by only 5.2% a year over the last 3 years.
- It earns only 2.9 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 32.7 USD for 1 USD of yearly profit. Over the last five years it was 29.4 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 5.6% a year over 5 years. Over the last 3 years it grew by 5.2% a year. For the next fiscal year analysts expect revenue to grow by 6.7%. Earnings per share fell by 2.0% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 44 USD
- Research and development 13 USD
- Sales and administration 32 USD
- Taxes and other 2.3 USD
- Net profit 9.5 USD
Net profit, industry median (Software - Infrastructure) 8.4 USD
Out of every 100 USD of revenue, 9.5 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 14.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 26
- Hold 25
- Sell 1
Today's price within the analysts' price targets
The average target of $167.27 is 90% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Reportable Segment 100%
By region
- UNITED STATES 51%
- Non-US 49%
Reportable Segment brings in 100% of revenue.
Segments in detail